Archive: Clinical Trial Participation

Since October is Breast Cancer Awareness Month, we’re examining how personalized medicine can improve treatment experiences and outcomes for breast cancer patients.

In an official guidance released in August, the FDA recommended avoiding the use of placebos in clinical trials for life-threatening diseases.

Direct-to-patient clinical trials may offer a solution for patient enrollment and retention woes.

A recent study shows that, while there is still progress to be made, clinical trials are implementing new tools to boost patient engagement.

Though patients are interested in clinical research, their doctors aren’t talking about clinical trials. Here’s how CROs and sponsors can continue to tap into patient interest.

Clinical trials often exclude patients over 70 years old from participating. Why has this become a trend, and what does it mean for the efficacy of clinical research?

Why do so many patients drop out of clinical trials? As it turns out, we can’t fix the ongoing patient retention problem without knowing the answer.

A fully digital clinical trial – where patients can participate from the comfort of their home – seems like a pipe dream. But as it turns out, it might not be.

New technology can improve the clinical trial experience for participants, but are sponsors and CROs on board with patient centricity?

Patient diversity in clinical trials is improving slowly – here’s one solution that might help speed things up.